Healthtech Startups

Caeli Vascular develops a medical device platform for the treatment of venous thrombotic disease, specifically designed to remove blood clots in deep vein thrombosis cases. The company targets physicians and healthcare institutions seeking to improve patient outcomes in interventional vascular care.

1 investor

Caelum Health develops software-based treatments for chronic digestive conditions including IBS, combining clinical data, medical expertise, and personalized coaching delivered through a digital platform.

1 investor

1 investor

Cagent Vascular develops endovascular medical devices, including the Serranator PTA Serration Balloon Catheter, for the treatment of vascular disease. The company serves vascular surgeons and interventionalists in the medical device industry.

1 investor

Caidya provides clinical trial management solutions designed for pharmaceutical and biotech companies seeking to improve trial efficiency and patient outcomes through integrated, patient-centric approaches.

1 investor

Caire Health develops AI software that analyzes medical imaging to assist emergency department teams in rapidly identifying critical conditions and triaging patients for immediate treatment.

1 investor

CAIRE develops and manufactures oxygen delivery equipment and services for medical and commercial applications, including products under its AirSep, HELiOS, and SeQual brands. Its customers include hospitals and military personnel who rely on high-performance oxygen delivery products.

1 investor

Cairns Health develops voice-activated software and radar-based monitoring devices for patients with chronic conditions, delivering medication reminders, symptom assessments, and activity tracking to coordinate care teams and reduce clinical costs.

1 investor

Cakehealth.com is a health information and product-review website presented as merged with Dualdiagnosis.org, covering topics such as CBD, medical trends, mental and physical health, and supplement product tests. The site publishes reviews and buying guides on health-related products for general consumers.

1 investor

Calder Biosciences develops protein-based subunit vaccines using its 3D-Vaxlock technology, which uses dityrosine crosslinking to lock immunogens into the shape they hold on a virus surface for improved antibody responses. Its engineered immunogens aim to offer better safety, efficacy, thermostability, and reduced cold chain requirements against infectious diseases.

1 investor

CALDRE is a Switzerland-based biotech spin-out developing liver-directed GalNAc-siRNA therapeutics, including its claudin-3 targeting candidate ClagalsiR, to restore bile flow and prevent fibrosis. It aims to treat cholestatic and fibrotic liver diseases such as primary sclerosing cholangitis and primary biliary cholangitis and reduce the need for liver transplantation.

1 investor

Calgary Scientific develops a mobile visualization platform for healthcare professionals that enables secure access to 2D/3D medical images for collaboration and diagnosis across any device without duplicating source files.

1 investor

Caliber is a fitness coaching program that combines data-driven fitness and nutrition programming, one-on-one video coaching, and habit coaching to help members build muscle and lose weight. It targets individuals seeking personalized, measurable body composition improvements.

1 investor

Calla Lily Clinical Care is a women's health company developing intravaginal drug delivery products based on its proprietary Callavid platform device, targeting IVF, prevention of preterm birth and miscarriage, delivery of live biotherapeutics to restore the vaginal microbiome, and biomarker sample collection for diagnostics such as endometriosis. Its FDA-cleared device technology serves the women's health and medical device market.

1 investor

Callara is a platform for 340B pharmacies, FQHCs, and clinics that logs drug decisions at the point of care, tracks them to the pharmacy fill, and verifies capture. It surfaces eligible OTC benefits, provides drug price intelligence factoring in 340B, patient assistance, formularies, and sliding scales, and offers a unified patient-messaging hub with AI-assisted responses.

1 investor

Holo is a personalized health platform that consolidates lab data, wearable insights, and imaging into a single actionable dashboard to help individuals proactively manage their wellbeing and extend healthspan. The platform serves consumers seeking preventive health management and longevity optimization in Europe.

1 investor

Calocurb is a natural, plant-based appetite suppressant capsule containing a patented hop extract that activates GLP-1 and other satiety hormones to reduce hunger and support weight management. The product is designed as a prescription-free alternative backed by clinical research and available in New Zealand.

1 investor

Life Log Technology develops "Calomeal" (カロミル), a health-management app that uses AI and machine learning to recognize and quantify the nutritional content of meals for diet and nutrition tracking. The company collects dietary data to support disease prevention and healthy-lifespan extension, and conducts machine learning research and development in Japan.

1 investor

Calorify measures individual metabolic rates and energy expenditure using doubly labeled water, a scientific method to quantify the calories people burn. The service targets individuals interested in understanding their personal metabolism and optimizing performance.

1 investor

Calosense provides a comprehensive weight loss platform offering clinical guidance and remote patient monitoring for GLP-1 therapy management.

1 investor

Calycia Bioscience is a biotechnology company developing engineered macrophage cell therapies delivered locally into the brain to target aggressive solid tumors of the central nervous system. Its pipeline focuses on glioblastoma and melanoma brain metastasis within CNS oncology.

1 investor

Calyx Health operates Mabel, a platform for voluntary alignment that automates outreach, response processing, analytics, and compliance for Accountable Care Organizations (ACOs) and health plans. It sends provider-branded communications to Medicare beneficiaries to grow enrollment in value-based care programs such as LEAD, ACO REACH, and GUIDE.

1 investor

Calyxha is a biotech company developing novel small molecule anti-inflammatory drugs for multiple inflammatory diseases. Its lead product, CAL-4, is in preclinical development as an alternative to corticosteroids for asthma.

1 investor

Calyxo develops medical devices for kidney stone removal, specifically a minimally invasive CVAC (Cavitation-Enabled Ablation and Clearance) system that has been FDA-cleared. The company serves urologists and patients seeking routine, single-treatment kidney stone management.

1 investor